Potential role of pemetrexed in metastatic breast cancer patients pre-treated with anthracycline or taxane
Objectives: This article reviews pharmacology, pharmacokinetic properties, clinical efficacy, and safety in metastatic breast cancer patients, as well as the predictive biomarkers for outcome of treatment with pemetrexed-based regimens. Methods: PubMed, Embase, OVID, and the Cochrane Library databas...
Guardado en:
Autores principales: | Li-Yan Zhou, Ye-Hui Shi, Yong-Sheng Jia, Zhong-Sheng Tong |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
KeAi Communications Co., Ltd.
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0e85f4e739c54bea9d4344b05a6e51e9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A Retrospective Analysis of the Effect of Irinotecan-Based Regimens in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes
por: Jiaojiao Suo, et al.
Publicado: (2021) -
Taxanes in the elderly patient with metastatic breast cancer
por: Yardley DA
Publicado: (2015) -
Taxanes in the elderly patient with metastatic breast cancer [Corrigendum]
por: Yardley DA
Publicado: (2019) -
Potential role of epicardial adipose tissue as a biomarker of anthracycline cardiotoxicity
por: Caterina Beatrice Monti, et al.
Publicado: (2021) -
A careful reassessment of anthracycline use in curable breast cancer
por: Sara Alsterlind Hurvitz, et al.
Publicado: (2021)